Ralpancizumab
Ralpancizumab Basic information
- Product Name:
- Ralpancizumab
- Synonyms:
-
- Ralpancizumab
- Research Grade Ralpancizumab (DHJ24006)
- Research Grade Ralpancizumab
- Ralpancizumab (anti-PCSK9)
- CAS:
- 1407495-04-8
- MW:
- 0
- Mol File:
- Mol File
More
Less
Ralpancizumab Usage And Synthesis
Uses
Ralpancizumab is a selective PCSK9 inhibitor with potential application in hemorrhagic stroke[1].
References
[1] Sanz-Cuesta BE, et al. Lipid-Lowering Therapy and Hemorrhagic Stroke Risk: Comparative Meta-Analysis of Statins and PCSK9 Inhibitors. Stroke. 2021 Oct;52(10):3142-3150. DOI:10.1161/STROKEAHA.121.034576
RalpancizumabSupplier
Shanghai YuanYe Biotechnology Co., Ltd.
- Tel
- 021-61312847; 18021002903
- 3008007409@qq.com
ShangHai Biochempartner Co.,Ltd
- Tel
- 177-54423994 17754423994
- 2853530910@QQ.com
Guangzhou Hongyuan Chemical Co.,Ltd
- Tel
- 15817493340
- 981810490@qq.com
Wuhan Chemstan Biotechnology Co., Ltd.
- Tel
- 027-65317797 15926423062
- 422450190@qq.com
Biolab Reagents
- Tel
- 027-65279366 18108604356
- products@biolabreagent.com